NCT03827564 - Goblet Cell Degranulation Produced by Intranasal Tear Neurostimulator (ITN) in Dry Eye Disease | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

June 24, 2019

Primary Completion Date

June 8, 2020

Study Completion Date

June 8, 2020

Conditions

Dry Eye Syndromes

Interventions

DEVICE

Intranasal Tear Neurostimulator (ITN) [TrueTear®]

The ITN applies a small electrical current to the nasal cavities to gently activate the body's natural tear production system.

Trial Locations (1)

Baylor College of Medicine - Department of Ophthalmology, Houston